Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 189.55

+3.5%

Dec 12 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: dwc who wrote (26820)	12/9/1998 7:44:00 AM
From: Henry Niman	Read Replies (1) of 32384

CNBC just did another update on AstraZeneca. They noted that overall companies were not leaders, but Astra was leading in treating ulcers and Zeneca was leading in cancer. Merger driven by patent expirations in 2001 as well as research costs. Noted that RP/HOE and Novartis were large competitors and speculated that AstraZeneca could be merged with another pharma.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next